Alpha Profiles · Company Profile

Autonomix Medical, Inc.

Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system.

https://registry.alpha.ac/companies/autonomix-medical-inc

Entity: Public listing published
Primary listing: NASDAQ: AMIX
Verification: Partially verified
Last reviewed: 2026-09-19T04:47:15.613914+00:00

Overview

Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company’s technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related diso

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

4 public records

Brad Hauser

Chief Executive Officer and President

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001437749-25-028954Sep 12, 2025

Landy Toth

Chief Technology Officer

State: unconfirmed
Effective: From Sep 12, 2025
Confidence: 88%
Evidence: DEF 14A amix20250831_def14a.htmSep 12, 2025

Robert Schwartz

Chief Medical Officer

State: unconfirmed
Effective: From Sep 12, 2025
Confidence: 88%
Evidence: DEF 14A amix20250831_def14a.htmSep 12, 2025

Trent Smith

Chief Financial Officer

State: unconfirmed
Effective: From Sep 12, 2025
Confidence: 88%
Evidence: DEF 14A amix20250831_def14a.htmSep 12, 2025

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Sep 19, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.